Weston, Canada Clinical Trials

A listing of Weston, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 69 clinical trials
5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:

Stereotactic Ablative Body Radiotherapy (SABR) given in 5 weekly fractions. Simultaneously treating the pelvic lymph nodes, prostate and MRI-nodule to a total dose of 25 Gy, 35 Gy and up to 50 Gy, respectively. The radiation will be given with 6-18 months of ADT. 5-fraction SABR is a feasible, well-tolerated, …

stereotactic body radiation therapy
adenocarcinoma of prostate
adenocarcinoma
Sunnybrook Health Sciences Center
 (7.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Hyperpolarized Imaging for New Treatments

The introduction of triple combination CFTR modulator therapy for patients with Cystic Fibrosis (CF) with at least one copy of the deltaF508 mutation is expected to provide major health benefits, but will also require novel outcome measures that can detect CF lung disease at an early stage, capture the efficacy …

antibiotics
pulmonary function test
cystic fibrosis
sweat chloride test
sweat test
The Hospital for Sick Kids
 (7.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
High Dose Accelerated iTBS for Depression

This trial will compare active intermittent theta burst stimulation (iTBS) rTMS in an accelerated treatment schedule (8 treatment sessions per day for 5 days) to a placebo control. Depression symptom severity will be measured before, during, at end of treatment, 1-week post and 4-weeks post treatment.

transcranial magnetic stimulation
depression
antidepressants
treatment regimen
depressive symptoms
CAMH
 (6.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
A Study to Evaluate the Safety Pharmacokinetics and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

kras
solid tumor
kras g12c mutation
ki-ras
metastatic malignant solid tumor
Princess Margaret Cancer Centre
 (6.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +7 other locations
Does Physiotherapy Plus Non-invasive Brain Stimulation Improve Motor Recovery in Children With Acquired Brain Injury?

The current study will evaluate the feasibility of transcranial direct current stimulation (tDCS) combined with an existing intensive physiotherapy program for children with ABI within the in/day-patient brain injury program at Holland Bloorview Kids Rehabilitation Hospital, Toronto, Canada. This feasibility randomized control trial will allocate 30 participants with ABI (age …

electrical stimulation
discomfort
perinatal brain injury
transcranial direct current stimulation
brain stimulation
Holland Bloorview Kids Rehabilitation Hospital
 (7.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic

The current study aims to assess the feasibility, acceptance and clinical outcomes of a practical high-dose aiTBS protocol, including tapering treatments and symptom-based relapse prevention treatments, in patients with unipolar depression previously responsive to ECT and patients needing urgent treatment due to symptom severity during the COVID-19 pandemic.

psychotic symptoms
covid-19
depression
major depressive disorder
depressive episode
CAMH
 (6.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Invasive Coronary Angiography Early in Ischemic Heart Failure

To compare the outcomes of patients with acute heart failure who undergo early coronary angiography vs. usual care

heart failure
angina pectoris
angina
angiography
heart disease
University Health Network
 (7.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

muscle rigidity
bradykinesia
tremor
genetic testing
methyldopa
Toronto Western Hospital
 (6.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +45 other locations
Molecular Characteristics of Gastroesophageal Adenocarcinoma (MOCHA): A Prospective Feasibility Study

Researchers are looking to further our knowledge on disease biology and treatment selection for gastroesophageal adenocarcinoma. The purpose of this study is to see how useful it is to look for changes and characteristics in your genes (molecules that contain instructions for the development and functioning of the cells) and …

University Health Network
 (7.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Thrombo-Elastography Guided Management of ECMO

Anticoagulation and coagulation management during ECMO is a challenge. Bleeding and clotting are major sources of morbidity and mortality. The currently used strategies are of poor evidence. This observational study wants to evaluate the use of automated thromboelastography (TEG 6s) to guide the management of coagulation and anticoagulation in patients …

thromboelastography
RET
hemorrhage
coagulopathy
University Health Network
 (6.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location